Augustina Isioma Ikusemoro: Thalassaemia is Not Just Anaemia – It’s a Genetic Story That Shapes
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Thalassaemia: It’s not just anaemia – it’s a genetic story that shapes outcomes.
Behind every microcytic blood film lies a deeper question:
Is this iron deficiency… or something inherited?
Thalassaemia is a disorder of globin chain synthesis, where the body cannot produce normal amounts of alpha or beta globin chains, leading to ineffective red cell production and varying degrees of anaemia.
Here’s what truly matters clinically:
The genetics define the disease
- Alpha-globin genes are located on chromosome 16
- Beta-globin genes are located on chromosome 11
Most α-thalassaemia cases are caused by gene deletions.
This is a key distinction – especially when interpreting microcytosis with normal iron studies.
Severity depends on how many gene copies are affected:
- Loss of 1–2 genes leads to mild or asymptomatic
- Loss of 3 genes leads to moderate to severe disease
- Loss of all 4 genes leads to Hydrops fetalis (Hb Bart’s) — often fatal without intervention
This is why thalassaemia should never be approached as ‘just another anaemia.’
It requires:
- Understanding of genetic patterns
- Correlation with RBC indices and Hb analysis
- Awareness of population risk and inheritance patterns
Because accurate diagnosis is not just academic – it directly impacts:
- Patient management
- Genetic counselling
- Prenatal outcomes
The real takeaway?
- Don’t just treat anaemia.
- Understand the biology behind it.
When you understand the genes, you diagnose with precision.
— Signature of Blood Doki
Educate.
Empower.
Elevate.”

Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy